GlassScriptPhysician profile
Twyla Landess
NPI 1457397333
$1,425.29
in general payments reported to CMS, 2019-2025
16 companies · $543 in 2025
The $543 reported for 2025 was more than what 97% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $303 · 2023: $206 · 2024: $373 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,121.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $374.50 | 2021-2025 | Entyvio, Gattex, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $223.07 | 2021-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $151.13 | 2021-2024 | Dificid |
| Nestle Healthcare Nutrition INC. | $107.29 | 2021-2023 | |
| Janssen Biotech, INC. | $96.68 | 2023-2025 | Tremfya, Stelara, Simponi |
| Madrigal Pharmaceuticals | $85.77 | 2024-2025 | Rezdiffra, Resmetirom |
| Qol Medical, LLC | $85.07 | 2025 | Sucraid |
| Ardelyx, INC. | $81.20 | 2024 | Ibsrela |
| Aimmune Therapeutics, INC. | $69.86 | 2024 | |
| Lilly USA, LLC | $56.36 | 2025 | Omvoh |
| Azurity Pharmaceuticals, INC. | $21.78 | 2025 | Suflave |
| Braintree Laboratories, INC. | $16.72 | 2023 | Suflave |
| Abbvie INC. | $16.27 | 2021 | |
| Intercept Pharmaceuticals, INC. | $14.73 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $14.32 | 2024 | Dupixent |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $10.54 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Twyla Landess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.